Period:
Draw Mode:
| Volume | 26,461 |
|
|||||
| News | - | ||||||
| Day High | 1.56 | Low High |
|||||
| Day Low | 1.4758 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Check Cap Ltd | CHEK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.05 | 3.33% | 1.55 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.52 | 1.4758 | 1.56 | 1.55 | 1.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 254 | 26,461 | $ 1.53 | $ 40,356 | - | 1.22 - 9.198 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:48:44 | 1 | $ 1.55 | USD |
Check Cap Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 71.66M | 46.23M | 5.84M | $ - | $ - | 3.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Check Cap News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHEK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.49 | 1.56 | 1.41 | 1.48 | 18,376 | 0.06 | 4.03% |
| 1 Month | 1.32 | 2.16 | 1.30 | 1.73 | 90,337 | 0.23 | 17.42% |
| 3 Months | 3.18 | 3.3615 | 1.22 | 1.65 | 67,680 | -1.63 | -51.26% |
| 6 Months | 3.53 | 5.90 | 1.22 | 2.64 | 60,365 | -1.98 | -56.09% |
| 1 Year | 7.30 | 9.198 | 1.22 | 5.83 | 270,659 | -5.75 | -78.77% |
| 3 Years | 10.398 | 89.80 | 1.22 | 30.69 | 3,498,173 | -8.85 | -85.09% |
| 5 Years | 83.00 | 94.80 | 1.22 | 30.29 | 2,252,658 | -81.45 | -98.13% |
Check Cap Description
| Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. |